Aristides Capital’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-134,100
Closed -$610K 264
2021
Q4
$610K Sell
134,100
-146,300
-52% -$1.11M 0.28% 87
2021
Q3
$2.01M Buy
280,400
+29,500
+12% +$217K 0.74% 28
2021
Q2
$2.02M Buy
250,900
+231,300
+1,180% +$1.95M 0.47% 32
2021
Q1
$133K Buy
+19,600
New +$130K 0.05% 118

Other funds holding OCGN

Aristides Capital's OCGN Position: Q1 2022 in Review

Aristides Capital sold out of Ocugen (OCGN) in Q1 2022, closing a stake of 50,010 shares — an estimated $228K sold.

Aristides Capital first reported a position in OCGN in Q2 2021 and held it in 3 quarters. The position peaked at $228K in Q4 2021. 122 funds tracked by Wall St. Rank hold OCGN as of Q1 2022.

  • Aristides Capital reported no remaining Ocugen position as of Q1 2022 after selling out during the quarter.
  • Aristides Capital sold 50,010 Ocugen shares in Q1 2022, an estimated $228K.
  • Aristides Capital first reported a position in Ocugen in Q2 2021 and held it in 3 quarters.
  • Aristides Capital's Ocugen position peaked at $228K in Q4 2021.
  • 122 funds tracked by Wall St. Rank held Ocugen as of Q1 2022.

Based on Aristides Capital's 13F filing for Q1 2022, filed 16 May 2022.